Back
Nektar Therapeutics Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
NKTR
Nektar Therapeutics
Last Price:
$57.53
Seasonality Move:
15.47%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiNektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 26.8% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 15 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.39%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $57.69. The Score for NKTR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 26.8% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 15 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.39%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
998.1M
Price in USD:
57.69
Volume:
476.1K
Beta:
1.25
Technical Analysis
SMA50:
58.66
SMA100:
45.79
SMA200:
29.35
52-Wk Change:
277.06%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 57.69 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 53.01 | 56.68 | 57.80 | 52.50 |
| Nov-17 | 57.81 | 59.58 | 60.80 | 57.05 |
| Nov-18 | 59.19 | 59.17 | 60.35 | 57.12 |
| Nov-19 | 59.17 | 60.35 | 61.81 | 58.27 |
| Nov-20 | 60.99 | 55.11 | 61.41 | 55.05 |
| Nov-21 | 55.30 | 54.28 | 56.50 | 53.29 |
| Nov-24 | 55.08 | 58.64 | 59.29 | 55.08 |
| Nov-25 | 58.64 | 60.35 | 61.00 | 58.01 |
| Nov-26 | 63.10 | 65.69 | 66.60 | 60.35 |
| Nov-28 | 66.41 | 65.21 | 66.86 | 64.25 |
| Dec-1 | 64.01 | 61.11 | 64.31 | 59.95 |
| Dec-2 | 61.11 | 54.85 | 61.40 | 54.65 |
| Dec-3 | 55.00 | 57.13 | 57.37 | 53.55 |
| Dec-4 | 56.90 | 57.69 | 57.86 | 54.75 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.22 per share, and a decrease next year of $2.08 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.